ScholarIQanswers from OpenAlex

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil

PaperCitations, authors & open-access status

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil have?

ScholarIQcitation count

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil has 133 citations in the OpenAlex counts ScholarIQ stores.

When was Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil published?

ScholarIQyear

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil has 2022 year in the ScholarIQ index.

What is the open-access status of Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil?

ScholarIQoa status

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil has hybrid oa status in the ScholarIQ index.

What is the DOI of Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil?

ScholarIQdoi

The DOI for Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil is on the source record.

What is the PMID of Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil?

ScholarIQpmid

The PMID for Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil is on the source record.

What is the OpenAlex record for Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil?

ScholarIQopenalex

The OpenAlex for Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial